Literature DB >> 2401706

Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test.

G F Lewis1, N M O'Meara, P A Soltys, J D Blackman, P H Iverius, A F Druetzler, G S Getz, K S Polonsky.   

Abstract

Abnormalities in fasting lipid and lipoprotein levels are known to occur in obesity and other hyperinsulinemic states. However, postprandial lipoprotein metabolism has not been studied systematically in obese subjects using sensitive techniques to distinguish between triglyceride-rich lipoprotein particles derived from the intestine and the liver. In the present study the vitamin A fat-loading test was used to label intestinally derived triglyceride-rich lipoprotein particles in the postprandial state. Lipid parameters in seven normolipidemic obese subjects [body mass index, 43.7 +/- 2.81 kg/m2 (mean +/- SEM)] were compared to those in eight matched normal weight controls (body mass index, 23.6 +/- 0.72 kg/m2) during the 24-h period following ingestion of a mixed meal with a high fat content to which vitamin A had been added. Although subjects were selected for normal fasting lipid levels, in the obese group fasting triglycerides were significantly higher (1.35 +/- 0.12 vs. 0.68 +/- 0.08 mmol/L; P less than 0.0005) and high density lipoprotein (HDL) cholesterol was lower (0.94 +/- 0.08 vs. 1.35 +/- 0.11 mmol/L; P less than 0.01). The obese subjects had a greater postprandial triglyceride response to the test meal (P less than 0.05). The cumulative increment in total plasma triglycerides was 3.35-fold greater in obese than control subjects, while that of retinyl ester was only 1.63-fold greater, suggesting that a significant portion of the postprandial triglyceride response is due to endogenous hepatic lipoproteins. Postprandial plasma triglyceride and retinyl ester increment correlated with basal triglycerides (r = 0.72; P less than 0.005 and r = 0.57; P less than 0.03, respectively) and negatively with fasting HDL (r = -0.51; P less than 0.05 and r = -0.60; P less than 0.02, respectively). In the obese, the HDL triglyceride content increased maximally 4 h postprandially (4.1% to 6.1%; P less than 0.005) and phospholipid at 12 h (25.8% to 28.7%; P less than 0.05), with lower cholesteryl ester (21.1% to 17.5%; P less than 0.002) at 8 h, reflecting exchange of surface and core lipids with triglyceride-rich particles after the meal. In obese and control subjects the magnitude of HDL triglyceride enrichment after the meal correlated positively with the postprandial triglyceride increment (r = 0.74; P less than 0.007) and negatively with the fasting HDL cholesterol concentration (r = -0.80; P = 0.002). We conclude that even normolipidemic obese subjects have greater postprandial lipemia and triglyceride enrichment of HDL after ingestion of a high fat meal.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401706     DOI: 10.1210/jcem-71-4-1041

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

2.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement.

Authors:  G F Lewis; N M O'Meara; V G Cabana; J D Blackman; W L Pugh; A F Druetzler; J R Lukens; G S Getz; K S Polonsky
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

4.  Effect of exercise on postprandial lipemia in men with hypertriglyceridemia.

Authors:  John Q Zhang; Lisa L Ji; Vicki S Fretwell; Guadalupe Nunez
Journal:  Eur J Appl Physiol       Date:  2006-09-28       Impact factor: 3.078

5.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

6.  The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.

Authors:  Jian Shen; Donna K Arnett; Pablo Pérez-Martínez; Laurence D Parnell; Chao-Qiang Lai; James M Peacock; James E Hixson; Michael Y Tsai; Robert J Straka; Paul N Hopkins; José M Ordovás
Journal:  J Lipid Res       Date:  2008-04-16       Impact factor: 5.922

7.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Authors:  B O Schneeman; L Kotite; K M Todd; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Vitamin A and D Absorption in Adults with Metabolic Syndrome versus Healthy Controls: A Pilot Study Utilizing Targeted and Untargeted LC-MS Lipidomics.

Authors:  Haley Chatelaine; Priyankar Dey; Xiaokui Mo; Eunice Mah; Richard S Bruno; Rachel E Kopec
Journal:  Mol Nutr Food Res       Date:  2020-12-07       Impact factor: 5.914

9.  Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity.

Authors:  Hawley E Kunz; Corey R Hart; Kevin J Gries; Mojtaba Parvizi; Marcello Laurenti; Chiara Dalla Man; Natalie Moore; Xiaoyan Zhang; Zachary Ryan; Eric C Polley; Michael D Jensen; Adrian Vella; Ian R Lanza
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-17       Impact factor: 4.310

10.  Predicting postprandial lipemia in healthy adults and in at-risk individuals with components of the cardiometabolic syndrome.

Authors:  R Scott Rector; Melissa A Linden; John Q Zhang; Shana O Warner; Thomas S Altena; Bryan K Smith; George G Ziogas; Ying Liu; Tom R Thomas
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.